H.F.L. Mark
Impact in
-
- Genomic variations and chromosomal abnormalities
-
- HER2/EGFR in Cancer Research
Papers in
- Genetics 24
- Genomic variations and chromosomal abnormalities 17
- BRCA gene mutations in cancer 5
- Genetics and Neurodevelopmental Disorders 3
- Co-authors
- L. Jeffrey Medeiros (1 shared paper)Roberto N. Miranda (1 shared paper)Marilyn M. Bui (2 shared papers)Edith Y. Wong (2 shared papers)Stuart C. Lauchlan (2 shared papers)R Mikumo (2 shared papers)Shuhua Yang (1 shared paper)Mary C. Lowery (1 shared paper)
- Journals
- Clinical Genetics (2 papers)Genetics in Medicine (2 papers)Journal of Medical Genetics (2 papers)Experimental and Molecular Pathology (1 paper)Annals of Human Genetics (1 paper)
- Partner nations
- United StatesPeruGermany
In The Last Decade
H.F.L. Mark
34 papers receiving 344 citations
Peers
Comparison fields: 5 of 65
- Genetics 138
- Oncology 92
- Cancer Research 46
- Pediatrics, Perinatology and Child Health 53
- Hematology 32
Countries citing papers authored by H.F.L. Mark
This map shows the geographic impact of H.F.L. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.F.L. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.F.L. Mark more than expected).
Fields of papers citing papers by H.F.L. Mark
This network shows the impact of papers produced by H.F.L. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.F.L. Mark. The network helps show where H.F.L. Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside H.F.L. Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. | 2000 | 52 |
| 2 | Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. | 1994 | 37 |
| 3 | 1977 | 26 | |
| 4 | Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study. | 1998 | 26 |
| 5 | Analysis of the growth properties and physical state of the human papillomavirus type 16 genome in cell lines derived from primary cervical tumors. | 1993 | 18 |
| 6 | 1999 | 16 | |
| 7 | Emerging molecular cytogenetic technologies. | 1997 | 16 |
| 8 | 2005 | 15 | |
| 9 | 1999 | 14 | |
| 10 | Fluorescent in situ hybridization assessment of chromosome copy number in gestational trophoblastic disease. | 1995 | 14 |
| 11 | 2000 | 13 | |
| 12 | 1998 | 12 | |
| 13 | Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. | 1995 | 12 |
| 14 | Breast cancer among Asian women. | 1996 | 11 |
| 15 | Cytogenetic characterization of three cell lines derived from primary cervical tumors. | 1995 | 9 |
| 16 | Assessment of sex chromosome composition using fluorescent in situ hybridization as an adjunct to GTG-banding. | 1995 | 9 |
| 17 | 1998 | 8 | |
| 18 | Fluorescent in situ hybridization assessment of chromosome copy number in buccal mucosal cells. | 1996 | 8 |
| 19 | Centromere index derivation by a novel and convenient approach. | 1993 | 6 |
| 20 | 2005 | 5 |
About H.F.L. Mark
H.F.L. Mark is a scholar working on Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health, Cancer Research and Plant Science, having authored 38 papers that have together received 363 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (17 papers), Prenatal Screening and Diagnostics (7 papers), Chromosomal and Genetic Variations (6 papers), BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers), Genetics and Neurodevelopmental Disorders (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Genetics (138 citations), Oncology (92 citations), Cancer Research (46 citations), Pediatrics, Perinatology and Child Health (53 citations) and Hematology (32 citations). H.F.L. Mark has collaborated with scholars based in United States, Peru and Germany. Frequent co-authors include L. Jeffrey Medeiros, Roberto N. Miranda, Marilyn M. Bui, Edith Y. Wong, Stuart C. Lauchlan, R Mikumo, Shuhua Yang, Mary C. Lowery, Diane L. Persons and L Braun. Their work appears in journals such as Clinical Genetics, Genetics in Medicine, Journal of Medical Genetics, Experimental and Molecular Pathology and Annals of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.